SCHEMBL10202452

SCHEMBL10202452

C#Cc1ccc2[nH]c(CN(CCC)C(=O)OC(C)(C)C)nc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 6/20 0.41
GABRG2 P18507 6/20 0.41
GABRB3 P28472 6/20 0.41
GABRA2 P47869 6/20 0.41
GABRA3 P34903 5/20 0.41
GABRA5 P31644 4/20 0.41
GABRA6 Q16445 4/20 0.41
GABRA4 P48169 3/20 0.41
CACNA1G O43497 1/20 0.37
CACNA1B Q00975 1/20 0.37
CACNA1C Q13936 1/20 0.37
HDAC1 Q13547 2/20 0.33
SSTR4 P31391 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC2 Q92769 1/20 0.33
NCOR2 Q9Y618 1/20 0.33
TDP1 Q9NUW8 1/20 0.32
LMNA P02545 2/20 0.32
ALDH1A1 P00352 2/20 0.32
USP2 O75604 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19339742 0.92 GABRA1 (0.39) GABRA1GABRG2GABRB3GABRA2GABRA3
SCHEMBL10201483 0.85 CACNA1G (0.39) CACNA1GCACNA1BCACNA1CHDAC1SSTR4
SCHEMBL10200220 0.85 CACNA1G (0.39) GABRA1GABRG2GABRB3GABRA2GABRA3
SCHEMBL19488484 0.84 GABRA1 (0.36) GABRA1GABRG2GABRB3GABRA2GABRA3
SCHEMBL19488495 0.80 GABRA1 (0.33) GABRA1GABRG2GABRB3GABRA2GABRA3
SCHEMBL19488790 0.79 GABRA1 (0.35) GABRA1GABRG2GABRB3GABRA2GABRA3
SCHEMBL19339591 0.78 HDAC3 (0.43) CACNA1GCACNA1BCACNA1CHDAC1SSTR4
SCHEMBL19488323 0.78 NPSR1 (0.51) CACNA1GCACNA1BCACNA1CTDP1ALDH1A1
SCHEMBL18526454 0.76 GABRA1 (0.37) GABRA1GABRG2GABRB3GABRA2GABRA3
SCHEMBL19488867 0.76 KDM4E (0.48) HDAC1HDAC3HDAC2NCOR2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012018325-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-02-09 WO disclosed